Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2022-12-31$0.15/sh−354$53→ 173,005 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.